Nothing Special   »   [go: up one dir, main page]

Saxenda VS Victoza

Download as pdf or txt
Download as pdf or txt
You are on page 1of 3

Saxenda VS Victoza

Saxenda® Victoza®
Active Ingredient Liraglutide Liraglutide

Dosage Forms And Pre-filled pen that delivers doses of Pre-filled pen that delivers doses of
Strengths 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg or 3 mg. 0.6 mg, 1.2 mg, or 1.8 mg.
(6 mg/mL) (6 mg/mL)

The Pen end with 3 The Pen end with 1.8

Indications Indicated as an adjunct to a reduced-calorie diet •As an adjunct to diet and exercise to improve
and increased physical activity for chronic weight glycemic control in adults with type 2 diabetes
management in adult patients with an initial body mellitus.
mass index (BMI) of •To reduce the risk of major adverse
• 30 kg/m2 or greater (obese) or cardiovascular events in adults with type 2
• 27 kg/m2 or greater (overweight) in the diabetes mellitus and established cardiovascular
presence of at least one weight-related comorbid disease.
condition (e.g. hypertension, type 2 diabetes
mellitus, or dyslipidemia).
The recommended dosage of Saxenda® is 3 mg Once daily at any time of day, independently of
Dosage daily without regard to the timing of meals. meals.

Initiate at 0.6 mg per day for one week then


increase to 1.2 mg.
Dose can be increased to 1.8 mg for additional
Evaluate the change in body weight 16 weeks glycemic control.
after initiating Saxenda® and discontinue
Saxenda® if the patient has not lost at least 4% of
baseline body weight.

Manufacturer

Supplier EBN SINA MEDICAL EST. EBN SINA MEDICAL EST.

Price 1,481.50 QR 733 QR


References - Conclusion:
https://www.novo- Saxenda & Victoza has the same active ingredient and the same manufacturer
pi.com/saxenda.pdf But the difference only in the Pen which differentiate between the uses of each
pen.
https://www.novo-
pi.com/victoza.pdf
Victoza pen is fractioned in smaller doses, starting with 0.6mg up to 1.8mg which
is ideal for diabetes treatment, as most of patients respond to lower daily doses
ranging from 0.6 to 1.8mg.
Saxenda, on the other hand, targets obesity treatment, which needs doses as
With best wishes high as 3mg/day.

Kulud Academy Team


- Remember:
* Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist.
Academy@kulud.com.qa * There are 6 families for management of Type 2 Diabetes Mellitus:
a) Insulin Secretagogues:
I) Sulphonyl Urea group (Glibenclamide or Glyburide), Gliclazide, Glipizide, Glimepiride,
Gliquidone and Tolbutamide).
II) Meglitinides (Repaglinide and Nateglinide).
b) Insulin Sensitizers:
I) Thiazolidinedione (Pioglitazone)
II) Biguanide (Metformin)
c) Alpha glucosidase inhibitors (Acarbose)
d) DiPeptidyl Peptidase 4 (DPP-4) inhibitors (Sitagliptin, Vildagliptin and Saxaglipin).
e) Glucagon-like peptide-1 (Liraglutide, Dulaglutide and Exenatide)
f) Sodium-Glucose co-Transporter (SGLT-2) inhibitors (Canagliflozin, Empagliflozin and
Dapagliflozin.)

You might also like